Skip to main content
SpringerLink
Log in

Selective cyclooxygenase-2 inhibitors: A review of recent chemical scaffolds with promising anti-inflammatory and COX-2 inhibitory activities

  • Review Article
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Selective cyclooxygenase-2 (COX-2) inhibitors have exhibited notable medicinal importance. In recent years, the discovery of new anti-inflammatory agents as selective COX-2 inhibitors has acquired more attention. This is due to the fact that currently available COX-2 inhibitors are linked with adverse effects. Various new organic scaffolds are being explored as new COX-2 inhibitors. In this review, we have mainly described different chemical scaffolds which have been investigated for COX-2 inhibition and anti-inflammatory activity. In the current review, literature from the last 10 years has been included. It will be helpful for organic and medicinal chemists to scrutinize new agents with minimum side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15
Fig. 16

Similar content being viewed by others

References

  • Abd-Ellah HS, Abdel-Aziz M, Shoman ME, Beshr EA, Kaoud T, Ahmed A-SF (2017) New 1, 3, 4-oxadiazole/oxime hybrids: design, synthesis, anti-inflammatory, COX inhibitory activities and ulcerogenic liability. Bioorg Chem 74:15–29

    CAS  PubMed  Google Scholar 

  • Abdel-Aziz HA, Al-Rashood KA, ElTahir KEH, Suddek GM (2014) Synthesis of N-benzenesulfonamide-1H-pyrazoles bearing arylsulfonyl moiety: novel celecoxib analogs as potent anti-inflammatory agents. Eur J Med Chem 80:416–422

    CAS  PubMed  Google Scholar 

  • Abdelall EK, Kamel GM (2016) Synthesis of new thiazolo-celecoxib analogues as dual cyclooxygenase-2/15-lipoxygenase inhibitors: determination of regio-specific different pyrazole cyclization by 2D NMR. Eur J Med Chem 118:250–258

    CAS  PubMed  Google Scholar 

  • Abdelgawad MA, Bakr RB, Azouz AA (2018) Novel pyrimidine-pyridine hybrids: synthesis, cyclooxygenase inhibition, anti-inflammatory activity and ulcerogenic liability. Bioorg Chem 77:339–348

    CAS  PubMed  Google Scholar 

  • Abdelgawad MA, Labib MB, Ali WA, Kamel G, Azouz AA, EL-Shaymaa E-N (2018) Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: histopathological and docking studies. Bioorg Chem 78:103–114

    CAS  PubMed  Google Scholar 

  • Abdellatif KR, Abdelgawad MA, Elshemy HA, Alsayed SS (2016) Design, synthesis and biological screening of new 4-thiazolidinone derivatives with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile. Bioorg Chem 64:1–12

    CAS  PubMed  Google Scholar 

  • Abdellatif KR, Abdelgawad MA, Elshemy HA, Alsayed SS, Kamel G (2015a) Synthesis and anti-inflammatory evaluation of new 1, 3, 5-triaryl-4, 5-dihydro-1H-pyrazole derivatives possessing an aminosulphonyl pharmacophore. Arch Pharmacal Res 38:1932–1942

    CAS  Google Scholar 

  • Abdellatif KR, Abdelgawad MA, Labib MB, Zidan TH (2015b) Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors. Bioorg Med Chem Lett 25:5787–5791

    CAS  PubMed  Google Scholar 

  • Abdellatif KR, Abdelgawad MA, Labib MB, Zidan TH (2017a) Synthesis and biological evaluation of new diarylpyrazole and triarylimidazoline derivatives as selective COX‐2 inhibitors. Arch Pharm 350:1600386

    Google Scholar 

  • Abdellatif KR, Chowdhury MA, Dong Y, Das D, Yu G, Velázquez C, Suresh MR, Knaus EE (2009) Diazen-1-ium-1, 2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies. Bioorgan Med Chem 17:5182–5188

    CAS  Google Scholar 

  • Abdellatif KR, Elsaady MT, Amin NH, Hefny AA (2017b) Design, synthesis and biological evaluation of some novel indole derivatives as selective COX-2 inhibitors. J Appl Pharm Sci 7:069–077

    CAS  Google Scholar 

  • Abdellatif KR, Elshemy HA, Azoz AA (2015c) 1-(4-Methane (amino) sulfonylphenyl)-3-(4-substituted-phenyl)-5-(4-trifluoromethylphenyl)-1H-2-pyrazolines/pyrazoles as potential anti-inflammatory agents. Bioorg Chem 63:13–23

    CAS  PubMed  Google Scholar 

  • Abolhasani H, Dastmalchi S, Hamzeh-Mivehroud M, Daraei B, Zarghi A (2016) Design, synthesis and biological evaluation of new tricyclic spiroisoxazoline derivatives as selective COX-2 inhibitors and study of their COX-2 binding modes via docking studies. Med Chem Res 25:858–869

    CAS  Google Scholar 

  • Ahmed M, Qadir MA, Shafiq MI, Muddassar M, Samra ZQ, Hameed A (2016) Synthesis, characterization, biological activities and molecular modeling of Schiff bases of benzene sulfonamides bearing curcumin scaffold. Arab J Chem 12:41–53

    Google Scholar 

  • Al-Hourani BJ, Sharma SK, Mane JY, Tuszynski J, Baracos V, Kniess T, Suresh M, Pietzsch J, Wuest F (2011) Synthesis and evaluation of 1, 5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors. Bioorg Med Chem Lett 21:1823–1826

    CAS  PubMed  Google Scholar 

  • Al-Hourani BJ, Sharma SK, Suresh M, Wuest F (2012) Novel 5-substituted 1H-tetrazoles as cyclooxygenase-2 (COX-2) inhibitors. Bioorg Med Chem Lett 22:2235–2238

    CAS  PubMed  Google Scholar 

  • Al-Suwaidan IA, Alanazi AM, El-Azab AS, Al-Obaid AM, ElTahir KE, Maarouf AR, El-Enin MAA, Alaa A-M (2013) Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2. Bioorg Med Chem Lett 23:2601–2605

    CAS  PubMed  Google Scholar 

  • Alaa A-M, El-Azab AS, Abou-Zeid LA, ElTahir KEH, Abdel-Aziz NI, Ayyad RR, Al-Obaid AM (2016) Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5, 5-diphenylimidazolidine-2, 4-dione scaffold: molecular docking studies. Eur J Med Chem 115:121–131

    Google Scholar 

  • Alam MJ, Alam O, Khan SA, Naim MJ, Islamuddin M, Deora GS (2016) Synthesis, anti-inflammatory, analgesic, COX1/2-inhibitory activity, and molecular docking studies of hybrid pyrazole analogues. Drug Des Dev Ther 10:3529

    CAS  Google Scholar 

  • Alanazi AM, El-Azab AS, Al-Suwaidan IA, ElTahir KEH, Asiri YA, Abdel-Aziz NI, Alaa A-M (2015) Structure-based design of phthalimide derivatives as potential cyclooxygenase-2 (COX-2) inhibitors: anti-inflammatory and analgesic activities. Eur J Med Chem 92:115–123

    CAS  PubMed  Google Scholar 

  • Alsayed SS, Elshemy HA, Abdelgawad MA, Abdel-Latif MS, Abdellatif KR (2017) Design, synthesis and biological screening of some novel celecoxib and etoricoxib analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile. Bioorg Chem 70:173–183

    CAS  PubMed  Google Scholar 

  • Ashif JS, Baranwal GJ, Ahmad S, Alam MS (2013) Phthalimides: biological profile and recent advancements. Res J Pharm Tech 6:1

    Google Scholar 

  • Badrey M, Abdel-Aziz H, Gomha S, Abdalla M, Mayhoub A (2015) Design and synthesis of imidazopyrazolopyridines as novel selective COX-2 inhibitors. Molecules 20:15287–15303

    CAS  PubMed  PubMed Central  Google Scholar 

  • Banerjee AG, Das N, Shengule SA, Sharma PA, Srivastava RS, Shrivastava SK (2016) Design, synthesis, evaluation and molecular modelling studies of some novel 5, 6-diphenyl-1, 2, 4-triazin-3 (2H)-ones bearing five-member heterocyclic moieties as potential COX-2 inhibitors: a hybrid pharmacophore approach. Bioorg Chem 69:102–120

    CAS  PubMed  Google Scholar 

  • Bano S, Javed K, Ahmad S, Rathish I, Singh S, Alam M (2011) Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents. Eur J Med Chem 46:5763–5768

    CAS  PubMed  Google Scholar 

  • Basile L, Álvarez S, Blanco A, Santagati A, Granata G, Di Pietro P, Guccione S, Muñoz-Fernández MÁ (2012) Sulfonilamidothiopyrimidone and thiopyrimidone derivatives as selective COX-2 inhibitors: synthesis, biological evaluation, and docking studies. Eur J Med Chem 57:149–161

    CAS  PubMed  Google Scholar 

  • Bechmann N, Kniess T, Köckerling M, Pigorsch A, Steinbach J, Pietzsch J (2015) Novel (pyrazolyl) benzenesulfonamides with a nitric oxide-releasing moiety as selective cyclooxygenase-2 inhibitors. Bioorg Med Chem Lett 25:3295–3300

    CAS  PubMed  Google Scholar 

  • Bertinaria M, Shaikh MAAG, Buccellati C, Cena C, Rolando B, Lazzarato L, Fruttero R, Gasco A, Hoxha M, Capra V (2012) Designing multitarget anti‐inflammatory agents: chemical modulation of the lumiracoxib structure toward dual thromboxane antagonists–COX‐2 inhibitors. Chem Med Chem 7:1647–1660

    CAS  PubMed  Google Scholar 

  • Bhat M, Al-Omar M, Raish M, Ansari M, Abuelizz H, Bakheit A, Naglah A (2018) Indole derivatives as cyclooxygenase inhibitors: synthesis, biological evaluation and docking studies. Molecules 23:1250

    PubMed Central  Google Scholar 

  • Boström J, Hogner A, Schmitt S (2006) Do structurally similar ligands bind in a similar fashion? J Med Chem 49:6716–6725

    PubMed  Google Scholar 

  • Cao Y, Prescott SM (2002) Many actions of cyclooxygenase‐2 in cellular dynamics and in cancer. J Cell Physiol 190:279–286

    CAS  PubMed  Google Scholar 

  • Chandak N, Kumar P, Kaushik P, Varshney P, Sharma C, Kaushik D, Jain S, Aneja KR, Sharma PK (2014) Dual evaluation of some novel 2-amino-substituted coumarinylthiazoles as anti-inflammatory–antimicrobial agents and their docking studies with COX-1/COX-2 active sites. J Enzym Inhib Med Chem 29:476–484

    CAS  Google Scholar 

  • Chin TS, Nasir FI, Hassan NI (2016) Synthesis and antimicrobial activities of eleven N-substituted maleimides. Malays J Anal Sci 20:741–750

    Google Scholar 

  • Coruzzi G, Venturi N, Spaggiari S (2007) Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond. Acta Biomed 78:96–110

    CAS  PubMed  Google Scholar 

  • Csende F, Miklós F, Porkoláb A (2013) Design and synthesis of some isoindoline derivatives as analogues of the active anti-inflammatory Indoprofen. Arkivoc 2:378–388

    Google Scholar 

  • Dawood DH, Batran RZ, Farghaly TA, Khedr MA, Abdulla MM (2015) New coumarin derivatives as potent selective COX‐2 inhibitors: Synthesis, anti‐Inflammatory, QSAR, and molecular modeling studies. Arch Pharm 348:875–888

    CAS  Google Scholar 

  • Desai D, Kaushal N, Gandhi UH, Arner RJ, D’Souza C, Chen G, Vunta H, El-Bayoumy K, Amin S, Prabhu KS (2010) Synthesis and evaluation of the anti-inflammatory properties of selenium-derivatives of celecoxib. Chem Biol Interact 188:446–456

    CAS  PubMed  PubMed Central  Google Scholar 

  • Di Capua A, Sticozzi C, Brogi S, Brindisi M, Cappelli A, Sautebin L, Rossi A, Pace S, Ghelardini C, Mannelli LDC (2016) Synthesis and biological evaluation of fluorinated 1, 5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity. Eur J Med Chem 109:99–106

    PubMed  Google Scholar 

  • Dogné J-M, Supuran CT, Pratico D (2005) Adverse cardiovascular effects of the coxibs. J Med Chem 48:2251–2257

    PubMed  Google Scholar 

  • Dube PN, Bule SS, Mokale SN, Kumbhare MR, Dighe PR, Ushir YV (2014) Synthesis and biologic evaluation of substituted 5‐methyl‐2‐phenyl‐1H‐pyrazol‐3 (2H)‐one derivatives as selective COX‐2 inhibitors: molecular docking study. Chem Biol Drug Des 84:409–419

    CAS  PubMed  Google Scholar 

  • Dündar Y, Ünlü S, Banoğlu E, Entrena A, Costantino G, Nunez M-T, Ledo F, Şahin MF, Noyanalpan N (2009) Synthesis and biological evaluation of 4, 5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors. Eur J Med Chem 44:1830–1837

    PubMed  Google Scholar 

  • Eberhart CE, Dubois RN (1995) Eicosanoids and the gastrointestinal tract. Gastroenterology 109:285–301

    CAS  PubMed  Google Scholar 

  • Farag DB, Farag NA, Esmat A, Abuelezz SA, Ibrahim EA-S, El Ella DAA (2015) Synthesis, 3D pharmacophore, QSAR and docking studies of novel quinazoline derivatives with nitric oxide release moiety as preferential COX-2 inhibitors. Med Chem Comm 6:283–299

    CAS  Google Scholar 

  • Firke SD, Bari SB (2015) Synthesis, biological evaluation and docking study of maleimide derivatives bearing benzenesulfonamide as selective COX-2 inhibitors and anti-inflammatory agents. Bioorgan Med Chem 23:5273–5281

    CAS  Google Scholar 

  • Fu Z-Y, Jin Q-H, Qu Y-L, Guan L-P (2019) Chalcone derivatives bearing chromen or benzo [f] chromen moieties: Design, synthesis, and evaluations of anti-inflammatory, analgesic, selective COX-2 inhibitory activities. Bioorg Med Chem Lett 29:1909–1912

    CAS  PubMed  Google Scholar 

  • Gassani BCA, Rezende RM, Paiva-Lima P, Ferreira-Alves DL, dos Reis WGP, Bakhle Y, de Francischi JN (2010) Is the sulphonamide radical in the celecoxib molecule essential for its analgesic activity? Pharm Res 62:439–443

    CAS  Google Scholar 

  • Ghareb N, Elshihawy HA, Abdel-Daim MM, Helal MA (2017) Novel pyrazoles and pyrazolo [1, 2-a] pyridazines as selective COX-2 inhibitors; Ultrasound-assisted synthesis, biological evaluation, and DFT calculations. Bioorg Med Chem Lett 27:2377–2383

    CAS  PubMed  Google Scholar 

  • Gorantla V, Gundla R, Jadav SS, Anugu SR, Chimakurthy J, Nidasanametla SK, Korupolu R (2017) Molecular hybrid design, synthesis and biological evaluation of N-phenyl sulfonamide linked N-acyl hydrazone derivatives functioning as COX-2 inhibitors: new anti-inflammatory, anti-oxidant and anti-bacterial agents. N J Chem 41:13516–13532

    CAS  Google Scholar 

  • Grover J, Bhatt N, Kumar V, Patel NK, Gondaliya BJ, Sobhia ME, Bhutani KK, Jachak SM (2015) 2, 5-Diaryl-1, 3, 4-oxadiazoles as selective COX-2 inhibitors and anti-inflammatory agents. RSC Adv 5:45535–45544

    CAS  Google Scholar 

  • Gupta AK, Gupta RA, Soni LK, Kaskhedikar S (2008) Exploration of physicochemical properties and molecular modelling studies of 2-sulfonyl-phenyl-3-phenyl-indole analogs as cyclooxygenase-2 inhibitors. Eur J Med Chem 43:1297–1303

    CAS  PubMed  Google Scholar 

  • Hassan GS, Abou-Seri SM, Kamel G, Ali MM (2014) Celecoxib analogs bearing benzofuran moiety as cyclooxygenase-2 inhibitors: design, synthesis and evaluation as potential anti-inflammatory agents. Eur J Med Chem 76:482–493

    CAS  PubMed  Google Scholar 

  • Hu W, Guo Z, Chu F, Bai A, Yi X, Cheng G, Li J (2003) Synthesis and biological evaluation of substituted 2-sulfonyl-phenyl-3-phenyl-indoles: a new series of selective COX-2 inhibitors. Bioorgan Med Chem 11:1153–1160

    CAS  Google Scholar 

  • Hudiyono S, Hanafi M, Yanuar A (2012) Synthesis and COX-2 Inhibitory Activity of 4-[(E)-2-(4-Oxo-3-phenyl-3, 4-dihydroquinazolin-2-yl) ethenyl] benzene-1-sulfonamide and its analogs. Pharmaceuticals 5:1282–1290

    PubMed  PubMed Central  Google Scholar 

  • Hwang SH, Wagner KM, Morisseau C, Liu J-Y, Dong H, Wecksler AT, Hammock BD (2011) Synthesis and structure−activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase. J Med Chem 54:3037–3050

    CAS  PubMed  PubMed Central  Google Scholar 

  • Khatri CK, Indalkar KS, Patil CR, Goyal SN, Chaturbhuj GU (2017) Novel 2-phenyl-4, 5, 6, 7-tetrahydro [b] benzothiophene analogues as selective COX-2 inhibitors: design, synthesis, anti-inflammatory evaluation, and molecular docking studies. Bioorg Med Chem Lett 27:1721–1726

    CAS  PubMed  Google Scholar 

  • Kim KJ, Choi MJ, Shin J-S, Kim M, Choi H-E, Kang SM, Jin JH, Lee K-T, Lee JY (2014) Synthesis, biological evaluation, and docking analysis of a novel family of 1-methyl-1H-pyrrole-2, 5-diones as highly potent and selective cyclooxygenase-2 (COX-2) inhibitors. Bioorg Med Chem Lett 24:1958–1962

    CAS  PubMed  Google Scholar 

  • Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, Penning TD, Seibert K, Isakson PC (1996) Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 384:644

    CAS  PubMed  Google Scholar 

  • Labib MB, Sharkawi SM, El-Daly M (2018) Design, synthesis of novel isoindoline hybrids as COX-2 inhibitors: Anti-inflammatory, analgesic activities and docking study. Bioorg Chem 80:70–80

    CAS  PubMed  Google Scholar 

  • Laube M, Gassner C, Sharma SK, Günther R, Pigorsch A, König J, Köckerling M, Wuest F, Pietzsch J, Kniess T (2015) Diaryl-substituted (dihydro) pyrrolo [3, 2, 1-hi] indoles, a class of potent COX-2 inhibitors with tricyclic core structure. J Org Chem 80:5611–5624

    CAS  PubMed  Google Scholar 

  • Laube M, Tondera C, Sharma SK, Bechmann N, Pietzsch F-J, Pigorsch A, Köckerling M, Wuest F, Pietzsch J, Kniess T (2014) 2, 3-Diaryl-substituted indole based COX-2 inhibitors as leads for imaging tracer development. RSC Adv 4:38726–38742

    CAS  Google Scholar 

  • Lill A, Scholich K, Stark H (2013) Synthesis of novel dansyl-labeled celecoxib derivatives. Tetrahedron Lett 54:6682–6686

    CAS  Google Scholar 

  • Lim C, Lee M, Park E-J, Cho R, Park H-J, Lee SJ, Cho H, Lee SK, Kim S (2010) Sulfonamide derivatives of styrylheterocycles as a potent inhibitor of COX-2-mediated prostaglandin E2 production. Bioorg Med Chem Lett 20:6938–6941

    CAS  PubMed  Google Scholar 

  • Lu X-Y, Wang Z-C, Ren S-Z, Shen F-Q, Man R-J, Zhu H-L (2016) Coumarin sulfonamides derivatives as potent and selective COX-2 inhibitors with efficacy in suppressing cancer proliferation and metastasis. Bioorg Med Chem Lett 26:3491–3498

    CAS  PubMed  Google Scholar 

  • Mahboubi Rabbani SMI, Zarghi A (2019) Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018). Expert Opin Ther Pat 29:407–427

    CAS  PubMed  Google Scholar 

  • McCormack K (1998) Roles of COX-1 and COX-2. J Rheumatol 25:2279–2281

    CAS  PubMed  Google Scholar 

  • Mitchell JA, Warner TD (1999) Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharm 128:1121–1132

    CAS  Google Scholar 

  • Moallem SA, Hadizadeh F, Yavar I (2011) New N-aryl-4-(methysulfony) aminobenzenesulfonamides as selective COX-2 inhibitors. J Biol Sci 11:496–499

    Google Scholar 

  • Mohamed LW, Shaaban MA, Zaher AF, Alhamaky SM, Elsahar AM (2019) Synthesis of new pyrazoles and pyrozolo [3, 4-b] pyridines as anti-inflammatory agents by inhibition of COX-2 enzyme. Bioorg Chem 83:47–54

    CAS  PubMed  Google Scholar 

  • Mohammed KO, Nissan YM (2014) Synthesis, molecular docking, and biological evaluation of some novel hydrazones and pyrazole derivatives as anti‐inflammatory agents. Chem Biol Drug Des 84:473–488

    CAS  PubMed  Google Scholar 

  • Moore RA, Derry S, McQuay HJ (2007) Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk. BMC Musculoskel Disord 8:73

    Google Scholar 

  • Murahari M, Mahajan V, Neeladri S, Kumar MS, Mayur Y (2019) Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors. Bioorg Chem 86:583–597

    CAS  PubMed  Google Scholar 

  • Navidpour L, Amini M, Miri R, Firuzi O, Tavakkoli M, Shafiee A (2014) Synthetic approaches towards the sulfonamide substituted‐1, 5‐diarylimidazole‐2‐thiones as selective cyclooxygense‐2 inhibitors. J Heterocycl Chem 51:71–79

    CAS  Google Scholar 

  • Okumura K, Ichihara K, Nagasaka M (1992) Effects of imidazoline-related compounds on the mechanical response to nicorandil in the rat portal vein. Eur J Pharm 215:253–257

    CAS  Google Scholar 

  • Palomer A, Cabré F, Pascual J, Campos J, Trujillo MA, Entrena A, Gallo MA, García L, Mauleón D, Espinosa A (2002) Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models. J Med Chem 45:1402–1411

    CAS  PubMed  Google Scholar 

  • Prasad BD, Vasanthi R, Kanth BC, Prabhakar D, Mohan MR (2012) Synthesis, characterization and anti-inflammatory activity of isatin derivatives. Int J Bio Pharm Res 3:182–187

    Google Scholar 

  • Prasit P, Wang Z, Brideau C, Chan C-C, Charleson S, Cromlish W, Ethier D, Evans J, Ford-Hutchinson A, Gauthier J (1999) The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2 (5H)-furanone], an orally active cyclooxygenase-2 inhibitor. Bioorg Med Chem Lett 9:1773–1778

    CAS  PubMed  Google Scholar 

  • Ragab FA, Heiba HI, El-Gazzar MG, Abou-Seri SM, El-Sabbagh WA, El-Hazek RM (2016) Synthesis of novel thiadiazole derivatives as selective COX-2 inhibitors. Med Chem Comm 7:2309–2327

    CAS  Google Scholar 

  • Rahman MA, Siddiqui AA (2010) Pyrazoline derivatives: a worthy insight into the recent advances and potential pharmacological activities. Int J Pharm Sci Drug Res 2:165–175

    CAS  Google Scholar 

  • Rathish I, Javed K, Ahmad S, Bano S, Alam M, Pillai K, Singh S, Bagchi V (2009) Synthesis and antiinflammatory activity of some new 1, 3, 5-trisubstituted pyrazolines bearing benzene sulfonamide. Bioorg Med Chem Lett 19:255–258

    CAS  PubMed  Google Scholar 

  • Reale A, Brogi S, Chelini A, Paolino M, Di Capua A, Giuliani G, Cappelli A, Giorgi G, Chemi G, Grillo A (2019) Synthesis, biological evaluation and molecular modeling of novel selective COX-2 inhibitors: sulfide, sulfoxide, and sulfone derivatives of 1, 5-diarylpyrrol-3-substituted scaffold. Bioorgan Med Chem 27:115045

    Google Scholar 

  • Regulski M, Piotrowska-Kempisty H, Prukała W, Dutkiewicz Z, Regulska K, Stanisz B, Murias M (2018) Synthesis, in vitro and in silico evaluation of novel trans-stilbene analogues as potential COX-2 inhibitors. Bioorgan Med Chem 26:141–151

    CAS  Google Scholar 

  • Ren S-Z, Wang Z-C, Zhu X-H, Zhu D, Li Z, Shen F-Q, Duan Y-T, Cao H, Zhao J, Zhu H-L (2018) Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition. Bioorgan Med Chem 26:4264–4275

    CAS  Google Scholar 

  • Renard J-F, Arslan D, Garbacki N, Pirotte B, de Leval X (2009) Pyridine analogues of nimesulide: design, synthesis, and in vitro and in vivo pharmacological evaluation as promising cyclooxygenase 1 and 2 inhibitors. J Med Chem 52:5864–5871

    CAS  PubMed  Google Scholar 

  • Renard J-F, Lecomte F, Hubert P, de Leval X, Pirotte B (2014) N-(3-Arylaminopyridin-4-yl) alkanesulfonamides as pyridine analogs of nimesulide: cyclooxygenases inhibition, anti-inflammatory studies and insight on metabolism. Eur J Med Chem 74:12–22

    CAS  PubMed  Google Scholar 

  • Ribeiro D, Poença C, Varela C, Janela J, da Silva EJT, Fernandes E, Roleira FM (2019) New phenolic cinnamic acid derivatives as selective COX-2 inhibitors. Design, synthesis, biological activity and structure-activity relationships. Bioorg Chem 91:103179

    PubMed  Google Scholar 

  • Riendeau D, Percival M, Brideau C, Charleson S, Dube D, Ethier D, Falgueyret J-P, Friesen R, Gordon R, Greig G (2001) Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharm Exp Ther 296:558–566

    CAS  Google Scholar 

  • Ryn Jv, Trummlitz G, Pairet M (2000) COX-2 selectivity and inflammatory processes. Curr Med Chem 7:1145–1161

    PubMed  Google Scholar 

  • Sabakhi I, Topuzyan V, Hajimahdi Z, Daraei B, Arefi H, Zarghi A (2015) Design, synthesis and biological evaluation of new 1, 4-dihydropyridine (DHP) derivatives as selective cyclooxygenase-2 inhibitors. Iran J Pharm Res 14:1087

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sarnpitak P, Mujumdar P, Morisseau C, Hwang SH, Hammock B, Iurchenko V, Zozulya S, Gavalas A, Geronikaki A, Ivanenkov Y (2014) Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core. Eur J Med Chem 84:160–172

    CAS  PubMed  Google Scholar 

  • Scheiman JM (2006) Unmet needs in non-steroidal anti-inflammatory drug-induced upper gastrointestinal diseases. Drugs 66:15–21

    CAS  PubMed  Google Scholar 

  • Shen F-Q, Wang Z-C, Wu S-Y, Ren S-Z, Man R-J, Wang B-Z, Zhu H-L (2017) Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX. Bioorg Med Chem Lett 27:3653–3660

    CAS  PubMed  Google Scholar 

  • Shrivastava SK, Srivastava P, Bandresh R, Tripathi PN, Tripathi A (2017) Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity. Bioorgan Med Chem 25:4424–4432

    CAS  Google Scholar 

  • Taher ES, Ibrahim TS, Fares M, Al-Mahmoudy AM, Radwan AF, Orabi KY, El-Sabbagh OI (2019) Novel benzenesulfonamide and 1, 2-benzisothiazol-3 (2H)-one-1, 1-dioxide derivatives as potential selective COX-2 inhibitors. Eur J Med Chem 171:372–382

    CAS  PubMed  Google Scholar 

  • Tietz O, Dzandzi J, Bhardwaj A, Valliant JF, Wuest F (2016) Design and synthesis of [125I] Pyricoxib: a novel 125I-labeled cyclooxygenase-2 (COX-2) inhibitors. Bioorg Med Chem Lett 26:1516–1520

    CAS  PubMed  Google Scholar 

  • Tietz O, Sharma SK, Kaur J, Way J, Marshall A, Wuest M, Wuest F (2013) Synthesis of three 18 F-labelled cyclooxygenase-2 (COX-2) inhibitors based on a pyrimidine scaffold. Org Biomol Chem 11:8052–8064

    CAS  PubMed  Google Scholar 

  • Uddin MJ, Rao PP, Knaus EE (2003) Design and synthesis of novel celecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of the sulfonamide pharmacophore by a sulfonylazide bioisostere. Bioorgan Med Chem 11:5273–5280

    CAS  Google Scholar 

  • Ugwu DI, Okoro UC, Ahmad H (2017) New carboxamide derivatives bearing benzenesulphonamide as a selective COX-II inhibitor: design, synthesis and structure-activity relationship. PLoS ONE 12:e0183807

    PubMed  PubMed Central  Google Scholar 

  • Unsal-Tan O, Ozadali K, Piskin K, Balkan A (2012) Molecular modeling, synthesis and screening of some new 4-thiazolidinone derivatives with promising selective COX-2 inhibitory activity. Eur J Med Chem 57:59–64

    CAS  PubMed  Google Scholar 

  • Vane J, Bakhle Y, Botting R (1998) Cyclooxygenases 1 and 2. Annu Rev Pharm Toxicol 38:97–120

    CAS  Google Scholar 

  • Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat N. Biol 231:232

    CAS  Google Scholar 

  • Wang M-T, Honn KV, Nie D (2007) Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev 26:525

    CAS  Google Scholar 

  • Zarghi A, Rao PP, Knaus EE (2007) Synthesis and biological evaluation of methanesulfonamide analogues of rofecoxib: Replacement of methanesulfonyl by methanesulfonamido decreases cyclooxygenase-2 selectivity. Bioorgan Med Chem 15:1056–1061

    CAS  Google Scholar 

  • Zayed MF, Hassan MH (2014) Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents. Saudi Pharm J 22:157–162

    Google Scholar 

  • Zhang Y, Wang Y, He C, Liu X, Lu Y, Chen T, Pan Q, Xiong J, She M, Tu Z (2017) Pentafluorosulfanyl-substituted benzopyran analogues as new cyclooxygenase-2 inhibitors with excellent pharmacokinetics and efficacy in blocking inflammation. J Med Chem 60:4135–4146

    CAS  PubMed  Google Scholar 

  • Zhou S, Yang S, Huang G (2017) Design, synthesis and bioactivities of Celecoxib analogues or derivatives. Bioorgan Med Chem 25:4887–4893

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Government College University, Faislalabad, 38000, Pakistan

    Noor-ul-Amin Mohsin

  2. Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, 38000, Pakistan

    Muhammad Irfan

Authors
  1. Noor-ul-Amin Mohsin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Muhammad Irfan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Noor-ul-Amin Mohsin.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohsin, NuA., Irfan, M. Selective cyclooxygenase-2 inhibitors: A review of recent chemical scaffolds with promising anti-inflammatory and COX-2 inhibitory activities. Med Chem Res 29, 809–830 (2020). https://doi.org/10.1007/s00044-020-02528-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-020-02528-1

Keywords

Search

Navigation